Search research articles
Contact Us
Filters
Showing results (541-550 of 569) with videos related to
Page
of 57
Sort By:
The American Journal of Surgical Pathology
|
October 19, 1999
The Spectrum of Cutaneous Lymphomas in HIV infection: a study of 21 cases
M Beylot-Barry, B Vergier, B Masquelier, et al.
The American Journal of Surgical Pathology
|
February 16, 1999
CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity? Groupe Français d'Etude des Lymphomes Cutanés (GFELC)
T Petrella, S Dalac, M Maynadié, et al.
The American Journal of Surgical Pathology
|
October 20, 1998
Statistical evaluation of diagnostic and prognostic features of CD30+ cutaneous lymphoproliferative disorders: a clinicopathologic study of 65 cases
B Vergier, M Beylot-Barry, K Pulford, et al.
The British Journal of Dermatology
|
October 17, 2020
International validation of the Bullous Pemphigoid Disease Area Index severity score and calculation of cut-off values for defining mild, moderate and severe types of bullous pemphigoid
W Masmoudi, M Vaillant, S Vassileva, et al.
Annales De Dermatologie Et De Venereologie
|
March 31, 2005
[Bullous pemphigoid in young patients: a retrospective study of 74 cases]
E Bourdon-Lanoy, J-C Roujeau, P Joly, et al.
The British Journal of Dermatology
|
January 23, 2016
Calculation of cut-off values based on the Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) and Pemphigus Disease Area Index (PDAI) pemphigus scoring systems for defining moderate, significant and extensive types of pemphigus
C Boulard, S Duvert Lehembre, C Picard-Dahan, et al.
British Journal of Cancer
|
May 4, 2016
First-in-human phase I study of the DNA-repair inhibitor DT01 in combination with radiotherapy in patients with skin metastases from melanoma
C Le Tourneau, B Dreno, Y Kirova, et al.
Dermatology (Basel, Switzerland)
|
January 20, 2004
Clinical criteria for the diagnosis of bullous pemphigoid: a reevaluation according to immunoblot analysis of patient sera
P Joly, Ph Courville, C Lok, et al.
The British Journal of Dermatology
|
June 26, 2021
International multicentre observational study to assess the efficacy and safety of a 0·5 mg kg<sup>-1</sup> per day starting dose of oral corticosteroids to treat bullous pemphigoid
V Hébert, S Bastos, K Drenovska, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
June 14, 2017
Factors associated with the choice of the first biologic in psoriasis: real-life analysis from the Psobioteq cohort
E Sbidian, C Giboin, H Bachelez, et al.
Page
of 57
Search research articles
Search
Showing results (541-550 of 569) with videos related to
Sort By:
Page
of 57
The American Journal of Surgical Pathology
|
October 19, 1999
The Spectrum of Cutaneous Lymphomas in HIV infection: a study of 21 cases
M Beylot-Barry, B Vergier, B Masquelier, et al.
The American Journal of Surgical Pathology
|
February 16, 1999
CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity? Groupe Français d'Etude des Lymphomes Cutanés (GFELC)
T Petrella, S Dalac, M Maynadié, et al.
The American Journal of Surgical Pathology
|
October 20, 1998
Statistical evaluation of diagnostic and prognostic features of CD30+ cutaneous lymphoproliferative disorders: a clinicopathologic study of 65 cases
B Vergier, M Beylot-Barry, K Pulford, et al.
The British Journal of Dermatology
|
October 17, 2020
International validation of the Bullous Pemphigoid Disease Area Index severity score and calculation of cut-off values for defining mild, moderate and severe types of bullous pemphigoid
W Masmoudi, M Vaillant, S Vassileva, et al.
Annales De Dermatologie Et De Venereologie
|
March 31, 2005
[Bullous pemphigoid in young patients: a retrospective study of 74 cases]
E Bourdon-Lanoy, J-C Roujeau, P Joly, et al.
The British Journal of Dermatology
|
January 23, 2016
Calculation of cut-off values based on the Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) and Pemphigus Disease Area Index (PDAI) pemphigus scoring systems for defining moderate, significant and extensive types of pemphigus
C Boulard, S Duvert Lehembre, C Picard-Dahan, et al.
British Journal of Cancer
|
May 4, 2016
First-in-human phase I study of the DNA-repair inhibitor DT01 in combination with radiotherapy in patients with skin metastases from melanoma
C Le Tourneau, B Dreno, Y Kirova, et al.
Dermatology (Basel, Switzerland)
|
January 20, 2004
Clinical criteria for the diagnosis of bullous pemphigoid: a reevaluation according to immunoblot analysis of patient sera
P Joly, Ph Courville, C Lok, et al.
The British Journal of Dermatology
|
June 26, 2021
International multicentre observational study to assess the efficacy and safety of a 0·5 mg kg<sup>-1</sup> per day starting dose of oral corticosteroids to treat bullous pemphigoid
V Hébert, S Bastos, K Drenovska, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
June 14, 2017
Factors associated with the choice of the first biologic in psoriasis: real-life analysis from the Psobioteq cohort
E Sbidian, C Giboin, H Bachelez, et al.
Page
of 57